Skip to content

Dissemination and Implementation of DIGEST™ as an Evidence-based Measurement Tool for Dysphagia: A Randomized Implementation Trial

Dissemination and Implementation of DIGEST™ as an Evidence-based Measurement Tool for Dysphagia: A Randomized Implementation Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07283653
Enrollment
85
Registered
2025-12-16
Start date
2025-06-01
Completion date
2029-01-31
Last updated
2026-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

DIGEST, Dysphagia, Evidence Based Measurement, Randomized Implementation

Brief summary

To improve swallowing outcomes in cancer through clinical implementation of the Dynamic Imaging Grade of Swallowing Toxicity (DIGEST™) as an evidence-based practice (EBP) tool to grade pharyngeal dysphagia (difficulty swallowing) as a toxicity of cancer.

Detailed description

Primary Objective Assess the impact of implementation strategies on clinical adoption (reach) of DIGEST for oncology MBS studies. Secondary Objective Assess the impact of implementation strategies on the fidelity (reliability) of DIGEST adoption for oncology MBS studies

Interventions

OTHERDIGEST Training + Practice Facilitation

Training plus practice facilitation

OTHERNo intervention

receive no active implementation

OTHERDIGEST Training Program

Investigator led training program

Sponsors

M.D. Anderson Cancer Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. A hospital or clinic affiliated with the Veteran's Affairs system, University of Wisconsin system, or Ohio State University system. 2. A minimum average of 10 Modified Barium Swallow (MBS) procedures per month in oncology patients in preceding year. 3. MBS imaging files are recorded and archived as a routine procedure (and accessible to researchers).

Exclusion criteria

N/A

Design outcomes

Primary

MeasureTime frame
Adoption of DIGEST in routine clinical documentation for oncology MBS studiesThrough study completion; an average of 1 year

Countries

United States

Contacts

CONTACTKate Hutcheson, PHD
karnold@mdanderson.org713-792-6513
PRINCIPAL_INVESTIGATORKate Hutcheson, PHD

M.D. Anderson Cancer Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026